title: β blockers in patients with heart failure and atrial fibrillation - Authors' reply.
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, Birmingham, UK; Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Australia. Electronic address: d.kotecha@bham.ac.uk.
authors.forename: Dipak
authors.initials: D
authors.lastname: Kotecha
authors.affiliation: Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
authors.forename: Douglas G
authors.initials: DG
authors.lastname: Altman
authors.affiliation: Internal Medicine Department, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
authors.forename: Luis
authors.initials: L
authors.lastname: Manzano
authors.affiliation: Norwich Medical School, University of East Anglia, Norwich, UK.
authors.forename: Marcus D
authors.initials: MD
authors.lastname: Flather
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000401:mortality*; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality*; D006801:Humans
chemical_list: D000319:Adrenergic beta-Antagonists